During the past decade, Clinical Research Consortium conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 27 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 18 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Consortium" #1 sponsor was "Pfizer" with 14 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored and "Altria Client Services LLC" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Consortium" #1 collaborator was "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Consortium" are "Osteoarthritis" (6 trials), "Arthritis" (3 trials), "Atopic Dermatitis" (3 trials), "Osteoarthritis, Knee" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Clinical Research Consortium" in a lesser frequency.

Most popular intervention types in "Clinical Research Consortium" are "Drug" (26 trials), "Biological" (10 trials), "Other" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "placebo" (4 trials), "tanezumab" (3 trials), "BMS-986165" (2 trials) and "PF-04965842" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Consortium" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Consortium". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Clinical Research Consortium, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Consortium, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".